Midwest Biomedical Accelerator Consortium: MBArC

中西部生物医学加速器联盟：MBArC

• 批准号: 10312631
• 负责人: William P Fay
• 金额: $ 35.11万
• 依托单位: UNIVERSITY OF MISSOURI-COLUMBIA
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-12-21 至 2023-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10312631
• 关键词: Adopted; Biosensing Techniques; Businesses; COVID-19; COVID-19 patient; COVID-19 screening; Capital; Chemicals; Clinic; Clinical; Communities; Detection; Disease; Exhalation; Goals; Head; Healthcare Systems; Home; Hospitals; Infrastructure; Logistics; Manufacturer Name; Measurement; Medical; Metals; Midwestern United States; Nose; Output; Pharmacy facility; Production; Quality Control; Ramp; Recovery; SARS-CoV-2 infection; Site; Stainless Steel; System; Technology; Testing; Time; Workplace; asymptomatic COVID-19; base; cost; design; detector; improved; innovation; novel; point of care; portability; response; screening; sensor; sensor technology; symptomatic COVID-19; urgent care; vector

The goal of this project is to establish robust, proof-of-concept feasibility for an innovative E-nose system, termed the MOF-SCENT system, for real-time and non-invasive screening for asymptomatic and symptomatic COVID-19 patients, with high accuracy based on the detection of VOCs emanating from exhaled breath. The proposed OE-HCCR-MOF based E-nose sensor is a novel biosensing and chemical sensing technology that will fundamentally advance E-nose sensing technologies due to the improved sensitivity and selectivity.

该项目的目标是为创新的电子鼻系统建立强大的概念验证可行性， 称为MOF-SCENT系统，用于无症状和有症状的实时和非侵入性筛查 COVID-19患者，基于呼出气体中挥发性有机化合物的检测，具有很高的准确性。的 提出的基于OE-HCCR-MOF的电子鼻传感器是一种新颖的生物传感和化学传感技术， 由于灵敏度和选择性的提高，将从根本上推进电子鼻传感技术。